Cargando…
Ursodeoxycholic acid versus phenobarbital for cholestasis in the Neonatal Intensive Care Unit
BACKGROUND: Although neonates and young infants with cholestasis are commonly treated with either phenobarbital or ursodeoxycholic acid (ursodiol), there is no evidence that phenobarbital is effective for this indication. Our objective was to compare the effectiveness of ursodiol and phenobarbital f...
Autores principales: | Lewis, Tamorah, Kuye, Simisola, Sherman, Ashley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011596/ https://www.ncbi.nlm.nih.gov/pubmed/29925342 http://dx.doi.org/10.1186/s12887-018-1167-y |
Ejemplares similares
-
The effects of ursodeoxycholic acid on sepsis-induced cholestasis management in an animal model
por: Ainosah, Randa H., et al.
Publicado: (2020) -
Ursodeoxycholic Acid and SMOFlipid for Treating Parenteral Nutrition Associated Cholestasis in Infants
por: Al-Alaiyan, Saleh, et al.
Publicado: (2022) -
Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial
por: Chappell, Lucy C, et al.
Publicado: (2019) -
Pilot study for a trial of ursodeoxycholic acid and/or early delivery for obstetric cholestasis
por: Gurung, Vinita, et al.
Publicado: (2009) -
Intrahepatic cholestasis of pregnancy: observational study of the treatment with low-dose ursodeoxycholic acid
por: Joutsiniemi, Titta, et al.
Publicado: (2015)